Results 161 to 170 of about 37,316 (268)

Comparative Efficacy of First‐Line Immune Checkpoint Inhibitor‐Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study

open access: yesInternational Journal of Urology, Volume 33, Issue 5, May 2026.
ABSTRACT Objectives Sarcomatoid renal cell carcinoma (sRCC) is an aggressive histological variant associated with a poor prognosis. While immune checkpoint inhibitor (ICI)‐based combinations have become the standard of care, the optimal first‐line regimen, specifically dual immunotherapy (IO‐IO) vs.
Keita Tamura   +15 more
wiley   +1 more source

Who can safely discontinue lifelong follow‐up among patients with sporadic pheochromocytoma and paraganglioma?

open access: yesJournal of Internal Medicine, Volume 299, Issue 5, Page 615-627, May 2026.
Abstract Background Current guidelines recommend at least 10 years of follow‐up for all pheochromocytoma and paraganglioma (PPGL) patients and lifelong monitoring for high‐risk individuals. Nonetheless, data identifying patients who may not require routine lifelong follow‐up are scarce. Methods Among 999 patients with PPGL, 703 who were non‐metastatic,
Min Jeong Park   +15 more
wiley   +1 more source

Primary Hyperparathyroidism in Adults: Recent Developments in Diagnosis and Management

open access: yesMedical Journal of Australia, Volume 224, Issue 5, May 2026.
ABSTRACT Primary hyperparathyroidism has a prevalence of around 1% in the general population. Diagnosis requires biochemical testing of serum (for calcium and parathyroid hormone) and urine (for calcium excretion), as well as wider screening for complications including osteoporosis, renal disease, abdominal symptoms and neuropsychiatric disturbance. In
Elizabeth Wootton   +5 more
wiley   +1 more source

Risk factors and prediction model for post-polypectomy metachronous colorectal adenoma. [PDF]

open access: yesInt J Colorectal Dis
Ma J   +8 more
europepmc   +1 more source

The Paradox of Metachronous Lipoid Pneumonia

open access: yesRespirology Case Reports
ABSTRACTA 70‐year‐old female patient diagnosed with stage IV EGFR‐mutant non–small‐cell lung cancer experienced three distinct instances of exogenous lipoid pneumonia while undergoing chemotherapy. Chest CT consistently revealed ground‐glass opacities with a crazy‐paving pattern, and bronchoscopy confirmed the presence of lipid‐laden, CD163‐positive ...
openaire   +2 more sources

Deep early tumour shrinkage in metastatic upper tract urothelial carcinoma treated with enfortumab vedotin plus pembrolizumab

open access: yes
BJU International, Volume 137, Issue 5, Page 790-793, May 2026.
Marie Semmler   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy